692
J. S. Ghomi, S. Zahedi
[1-(2,4-Dichlorophenyl)-1,2-dihydro-3H-naphtho[1,2-e][1,3]-
oxazine-3-ylidene]malonaldehyde (5e, C21H13Cl2NO3)
[1,2-Dihydro-1-(4-hydroxyphenyl)-3H-naphtho[1,2-e][1,3]-
oxazine-3-ylidene]malonaldehyde (5k, C21H15NO4)
ꢀ
ꢀ
Yellow solid; IR (KBr): m = 3,409, 1,620, 1,510, 1,449,
Yellow solid; IR (KBr): m = 3,405, 1,626, 1,514, 1,449,
1
1
1,220, 826 cm-1; H NMR (400 MHz, CDCl3): d = 6.22
1,220, 822 cm-1; H NMR (400 MHz, CDCl3): d = 6.23
(s, 1H), 7.19–7.25 (d, 2H), 7.49–7.62 (d, 2H), 7.65–7.70 (d,
2H), 7.89–7.93 (d, 2H), 8.11 (s, 1H), 10.03 (br s, 2H,
CHO), 12.28 (s, 1H) ppm; 13C NMR (100 MHz, CDCl3):
d = 50.3, 101.3, 113.4, 117.2, 123.1, 124.3, 126.8, 128.8,
128.9, 129.6, 130.1, 131.7, 131.8, 131.9, 134.5, 143.0,
144.8, 148.6, 162.1, 186.7 ppm.
(s, 1H), 7.18–7.24 (d, 2H), 7.47–7.63 (d, 2H), 7.63–7.71 (d,
2H), 7.89–7.93 (d, 2H), 8.11 (s, 1H), 9.45 (s, 1H), 10.01 (br
s, 2H, CHO), 12.29 (s, 1H) ppm; 13C NMR (100 MHz,
CDCl3): d = 50.3, 101.3, 113.4, 117.2, 123.1, 124.3,
126.8, 128.8, 128.9, 129.6, 130.1, 131.7, 131.8, 131.9,
134.5, 143.0, 144.8, 148.6, 162.1, 186.7 ppm.
[1,2-Dihydro-1-(4-methylphenyl)-3H-naphtho[1,2-e][1,3]-
oxazine-3-ylidene]malonaldehyde (5f, C22H17NO3)
[1-(2,4-Dimethoxyphenyl)-1,2-dihydro-3H-naphtho[1,2-e]-
[1,3]oxazine-3-ylidene]malonaldehyde (5l, C23H19NO5)
ꢀ
ꢀ
Yellow solid; IR (KBr): m = 3,408, 1,628, 1,515, 1,453,
Yellow solid; IR (KBr): m = 3,397, 1,628, 1,515, 1,449,
1
1
1,219, 821 cm-1; H NMR (400 MHz, CDCl3): d = 2.30
1,220, 821 cm-1; H NMR (400 MHz, CDCl3): d = 3.72
(s, 3H), 6.20 (s, 1H), 7.10–7.13 (d, 2H), 7.15–7.20 (d, 2H),
7.42–7.48 (t, 3H), 7.58 (d, 1H), 7.84 (d, 1H), 7.97 (d, 1H),
10.03 (br s, 2H, CHO), 12.26 (s, 1H) ppm; 13C NMR
(100 MHz, CDCl3): d = 23.3, 50.2, 101.1, 113.4, 117.9,
123.3, 125.7, 127.3, 128.5, 128.9, 129.6, 130.4, 131.7,
131.8, 132.9, 134.5, 142.9, 144.4, 147.8, 162.2, 186.8 ppm.
(s, 6H), 6.22 (s, 1H), 7.19–7.25 (d, 2H), 7.49–7.62 (d, 2H),
7.65–7.70 (d, 2H), 7.89–7.93 (d, 2H), 8.11 (s, 1H), 10.03
(br s, 2H, CHO), 12.28 (s, 1H) ppm; 13C NMR (100 MHz,
CDCl3): d = 50.1, 53.5, 53.6, 101.2, 113.4, 117.2, 123.1,
124.3, 126.8, 128.8, 128.9, 129.6, 130.2, 131.7, 131.8,
131.9, 134.5, 143.0, 144.8, 148.4, 163.6, 186.9 ppm.
[1,2-Dihydro-1-(4-methoxyphenyl)-3H-naphtho[1,2-e][1,3]-
oxazine-3-ylidene]malonaldehyde (5g, C22H17NO4)
[1,2-Dihydro-1-(naphthalen-1-yl)-3H-naphtho[1,2-e][1,3]-
oxazine-3-ylidene]malonaldehyde (5m, C25H17NO3)
ꢀ
ꢀ
Yellow solid; IR (KBr): m = 3,403, 1,624, 1,513, 1,449,
Yellow solid; IR (KBr): m = 3,404, 1,623, 1,510, 1,449,
1
1,220, 819 cm-1; H NMR (400 MHz, CDCl3): d = 3.48
1,220, 826 cm-1 1H NMR (400 MHz, CDCl3):
;
(s, 3H), 6.21 (s, 1H), 7.18-7.26 (d, 2H), 7.45-7.60 (d, 2H),
7.63-7.72 (d, 2H), 7.87–7.91 (d, 2H), 8.08 (s, 1H), 10.02
(br s, 2H, CHO), 12.24 (s, 1H) ppm; 13C NMR (100 MHz,
CDCl3): d = 33.5, 50.1, 101.1, 113.4, 117.2, 123.1, 124.3,
126.8, 128.8, 128.9, 129.6, 130.4, 131.7, 131.8, 131.9,
134.2, 143.5, 145.4, 148.4, 162.2, 187.2 ppm.
d = 7.20–7.27 (m, 3H), 7.36–7.42 (m, 4H), 7.61 (d, 1H),
7.70–7.82 (m, 3H), 7.89–8.01 (d, 3H), 8.77(d, 1H), 10.01
(br s, 2H, CHO), 12.27 (s, 1H) ppm; 13C NMR (100 MHz,
DMSO-d6): d = 53.4, 101.1, 118.7, 119.3, 122.8, 123.5,
123.9, 125.5, 125.7, 125.9, 126.5, 126.7, 127.9, 129.0,
129.2, 129.7, 131.5, 133.3, 134.0, 137.8, 144.8, 148.4,
163.6, 186.9 ppm.
[1,2-Dihydro-1-(4-isopropylphenyl)-3H-naphtho[1,2-e][1,3]-
oxazine-3-ylidene]malonaldehyde (5h, C24H21NO3)
Acknowledgments The authors are grateful to Islamic Azad Uni-
versity, Qom Branch, for financial support of this work.
ꢀ
Yellow solid; IR (KBr): m = 3,407, 1,619, 1,513, 1,454,
1
1,220, 834 cm-1; H NMR (400 MHz, CDCl3): d = 1.19
(d, 6H), 2.84 (m, 1H), 6.20 (s, 1H), 7.19–7.25 (d, 3H),
7.49–7.62 (t, 3H), 7.89–7.93 (t, 2H), 8.12 (m, 2H), 10.02
(br s, 2H, CHO), 12.26 (s, 1H) ppm; 13C NMR (100 MHz,
CDCl3): d = 23.2, 33.5, 50.3, 101.3, 113.4, 117.2, 123.1,
124.3, 126.8, 128.8, 128.9, 129.6, 130.1, 131.7, 131.8,
131.9, 134.5, 143.0, 144.8, 148.6, 162.1, 186.7 ppm.
References
1. Sasaki K, Kusakabe Y, Esumi S (1972) J Antibiot 25:151
2. Johnson PY, Silver RB (1975) J Heterocycl Chem 10:1029
3. Lesher GY, Surrey AR (1955) J Am Chem Soc 77:636
4. Mosher HS, Frankel MB, Gregory M (1953) J Am Chem Soc
75:5326
[1-(4-Bromophenyl)-1,2-dihydro-3H-naphtho[1,2-e][1,3]-
oxazine-3-ylidene]malonaldehyde (5j, C21H14BrNO3)
5. Ren H, Grady S, Gamenara D, Heinzen H, Moyna P, Croft S,
Kendrick H, Yardley V, Moyna G (2001) Bioorg Med Chem Lett
11:1851
ꢀ
Yellow solid; IR (KBr): m = 3,410, 1,620, 1,513, 1,446,
´
6. Benedini F, Bertolini G, Cereda R, Dona G, Gromo G, Levi S,
1
1,220, 815 cm-1; H NMR (400 MHz, CDCl3): d = 6.20
Mizrahi J, Sala A (1995) J Med Chem 38:130
7. Clark RD, Caroon JM, Kluge AF, Repke DB, Roszkowski AP,
Strosberg AM, Baker S, Bitter SM, Okada MD (1983) J Med
Chem 26:657
8. Matsuoka H, Ohi N, Mihara M, Suzuki H, Miyamoto K, Mar-
uyama N, Tsuji K, Kato N, Akimoto T, Takeda Y, Yano K,
Kuroki T (1997) J Med Chem 40:105
(s, 1H), 7.13–7.15 (d, 2H), 7.18–7.20 (d, 2H), 7.46–7.49 (t,
3H), 7.61 (d, 1H), 7.88 (d, 1H), 7.96 (d, 1H), 10.01 (br s,
2H, CHO), 12.27 (s, 1H) ppm; 13C NMR (100 MHz,
CDCl3): d = 50.5, 101.1, 113.3, 118.2, 123.5, 124.4,
127.3, 128.8, 128.9, 129.6, 130.2, 131.7, 131.8, 131.9,
134.5, 143.6, 145.4, 148.6, 162.4, 186.8 ppm.
9. Khumtaveeporn K, Alper H (1995) J Org Chem 60:8142
123